Xinna Deng

575 total citations
16 papers, 426 citations indexed

About

Xinna Deng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinna Deng has authored 16 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinna Deng's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Risks and Factors (2 papers). Xinna Deng is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Risks and Factors (2 papers). Xinna Deng collaborates with scholars based in China and Canada. Xinna Deng's co-authors include Haijiang Wu, Jinying Wei, Huijun Duan, Yonghong Shi, Ye Su, Qingxia Li, Zhu‐Xu Zhang, Alexander Pavlosky, Anthony M. Jevnikar and Linglin Zou and has published in prestigious journals such as PLoS ONE, eLife and Medicine.

In The Last Decade

Xinna Deng

15 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinna Deng China 10 275 182 75 50 32 16 426
Youming Guo United States 12 235 0.9× 131 0.7× 42 0.6× 48 1.0× 47 1.5× 16 440
Jiro Ikeda Japan 11 169 0.6× 142 0.8× 75 1.0× 49 1.0× 56 1.8× 14 404
Yanrui Huang China 8 237 0.9× 143 0.8× 34 0.5× 71 1.4× 25 0.8× 11 374
Mengyue Yang China 9 207 0.8× 67 0.4× 36 0.5× 36 0.7× 28 0.9× 18 319
Alba Bosquet Spain 6 225 0.8× 95 0.5× 49 0.7× 75 1.5× 19 0.6× 7 329
Filippo Zeni Italy 5 169 0.6× 113 0.6× 77 1.0× 37 0.7× 44 1.4× 7 423
Songping Yu China 12 182 0.7× 65 0.4× 55 0.7× 57 1.1× 36 1.1× 25 398
Zhongwen Qi China 13 330 1.2× 107 0.6× 51 0.7× 49 1.0× 39 1.2× 18 500
Wen Meng China 11 156 0.6× 96 0.5× 122 1.6× 100 2.0× 33 1.0× 18 387
Chengcheng Xiao China 11 331 1.2× 182 1.0× 17 0.2× 64 1.3× 37 1.2× 18 469

Countries citing papers authored by Xinna Deng

Since Specialization
Citations

This map shows the geographic impact of Xinna Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinna Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinna Deng more than expected).

Fields of papers citing papers by Xinna Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinna Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinna Deng. The network helps show where Xinna Deng may publish in the future.

Co-authorship network of co-authors of Xinna Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinna Deng. A scholar is included among the top collaborators of Xinna Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinna Deng. Xinna Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Deng, Xinna, Jinying Wei, Zhaohua Yang, et al.. (2024). Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway. PLoS ONE. 19(6). e0299389–e0299389.
2.
Deng, Xinna, et al.. (2023). Global research trends in unilateral ureteral obstruction-induced renal fibrosis: A bibliometric and visualized study. Medicine. 102(32). e34713–e34713. 1 indexed citations
3.
Deng, Xinna, et al.. (2023). Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker. Cancers. 15(21). 5235–5235. 8 indexed citations
4.
Chen, Ling‐Yun, Yang Li, & Xinna Deng. (2023). Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker. Medicine. 102(11). e33242–e33242. 4 indexed citations
5.
Li, Yang, et al.. (2022). Effect of Metformin Therapy on Biological Properties and Prognosis of Breast Cancer Patients Complicated with Type-2 Diabetes. Pakistan Journal of Medical Sciences. 38(5). 1193–1198. 1 indexed citations
6.
Wei, Jinying, Xinna Deng, Runmei Li, et al.. (2021). PP2 Ameliorates Renal Fibrosis by Regulating the NF‐κB/COX‐2 and PPARγ/UCP2 Pathway in Diabetic Mice. Oxidative Medicine and Cellular Longevity. 2021(1). 7394344–7394344. 15 indexed citations
8.
Qian, Dong, Huajun Qu, Xinna Deng, et al.. (2021). m6A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discovery. 7(1). 27–27. 52 indexed citations
9.
Zhang, Yunxia, Junjiang Liu, Fei Gao, et al.. (2020). Circular RNA cir‐ITCH Is a Potential Therapeutic Target for the Treatment of Castration‐Resistant Prostate Cancer. BioMed Research International. 2020(1). 7586521–7586521. 23 indexed citations
10.
Shi, Dongjian, Lixia Zhang, Dongmiao Wang, et al.. (2019). Association of body mass and systemic immune-inflammation indices with endocrine therapy resistance in luminal breast cancers. Journal of International Medical Research. 47(5). 1936–1947. 12 indexed citations
11.
Li, Nan, Liang Yang, Xinna Deng, & Yanan Sun. (2018). Effects of isoliquiritigenin on ovarian cancer cells. OncoTargets and Therapy. Volume 11. 1633–1642. 18 indexed citations
12.
Deng, Xinna, et al.. (2017). Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome. Oncology Letters. 13(6). 4734–4740. 3 indexed citations
13.
Deng, Xinna, Haijiang Wu, Fei Gao, et al.. (2017). Brachytherapy in the treatment of breast cancer. International Journal of Clinical Oncology. 22(4). 641–650. 21 indexed citations
14.
Su, Ye, Haijiang Wu, Alexander Pavlosky, et al.. (2016). Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death and Disease. 7(8). e2333–e2333. 91 indexed citations
15.
Wu, Haijiang, et al.. (2016). PGC-1α, glucose metabolism and type 2 diabetes mellitus. Journal of Endocrinology. 229(3). R99–R115. 126 indexed citations
16.
Wu, Haijiang, Yonghong Shi, Xinna Deng, et al.. (2015). Inhibition of c-Src/p38 MAPK pathway ameliorates renal tubular epithelial cells apoptosis in db/db mice. Molecular and Cellular Endocrinology. 417. 27–35. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026